Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated No phase listed Observational

NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial

ClinicalTrials.gov ID: NCT04698681

Public ClinicalTrials.gov record NCT04698681. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes in Patients With Stage IV, 1L Non-Small Cell Lung Cancer to Determine Eligibility for the KEAPSAKE Clinical Trial (NCT04265534)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter screening protocol designed to identify patients with NSCLC who have tumor mutations in the KEAP1 or NRF2/NFE2L2 genes in order to determine potential eligibility for a biomarker selected clinical trial (CX-839-014, otherwise known as the KEAPSAKE trial). Circulating tumor DNA (ctDNA) present in blood samples collected from eligible patients will be analyzed by next generation sequencing (NGS) for selected biomarkers. A commercial liquid biopsy NGS test will be provided to study participants free of charge.

Study identification

NCT ID
NCT04698681
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Calithera Biosciences, Inc
Industry
Enrollment
20 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 19, 2021 (Actual)
Primary completion
Nov 5, 2021 (Actual)
Completion
Feb 9, 2022 (Actual)
Last update posted
Mar 13, 2023

2021 – 2022

United States locations

U.S. sites
63
U.S. states
12
U.S. cities
55
Facility City State ZIP Site status
Southern Cancer Center Daphne Alabama 36526 —
Southern Cancer Center - 3 Mobile Infirmary Circle Mobile Alabama 36607 —
Southern Cancer Center - Dauphin St Mobile Alabama 36608 —
Southern Cancer Center - Providence Hospital Mobile Alabama 36608 —
Arizona Oncology Associates - Glendale Glendale Arizona 85308 —
Arizona Oncology Associates - E. Highland Ave. Phoenix Arizona 85016 —
Arizona Oncology Associates - N. 27th Ave. Phoenix Arizona 85027 —
Arizona Oncology Associates Scottsdale Arizona 85258 —
Arizona Oncology Associates - Tempe Tempe Arizona 85284 —
Rocky Mountain Cancer Centers - Aurora Aurora Colorado 80012 —
Rocky Mountain Cancer Centers - Boulder Boulder Colorado 80303 —
Rocky Mountain Cancer Centers - Centennial Centennial Colorado 80112 —
Rocky Mountain Cancer Centers - Colorado Springs Colorado Springs Colorado 80907 —
Rocky Mountain Cancer Centers - Williams Street Denver Colorado 80218 —
Rocky Mountain Cancer Centers - E. Hale Parkway Denver Colorado 80220 —
Rocky Mountain Cancer Centers - Englewood Englewood Colorado 80113 —
Rocky Mountain Cancer Centers - Lakewood Lakewood Colorado 80228 —
Rocky Mountain Cancer Centers - Littleton Littleton Colorado 80120-4413 —
Rocky Mountain Cancer Centers - Lone Tree Lone Tree Colorado 80124 —
Rocky Mountain Cancer Centers - Longmont Longmont Colorado 80501 —
Rocky Mountain Cancer Centers - Pueblo Pueblo Colorado 81008 —
Rocky Mountain Cancer Centers - Thornton Thornton Colorado 80260 —
Medical Oncology Hematology Consultants Newark Delaware 19713 —
Woodlands Medical Specialists Pensacola Florida 32503 —
Maryland Oncology Hematology - Bethesda Bethesda Maryland 20817 —
Maryland Oncology Hematology - Brandywine Brandywine Maryland 20613 —
Maryland Oncology Hematology - Clinton Clinton Maryland 20735 —
Maryland Oncology Hematology Columbia Maryland 21044 —
Maryland Hematology Oncology - Frederick Frederick Maryland 21702 —
Maryland Oncology Hematology - Lanham Lanham Maryland 20706 —
Maryland Hematology Oncology - Rockville Rockville Maryland 20850 —
Maryland Hematology Oncology - Silver Spring Silver Spring Maryland 20904 —
Oncology Hematology Care - Mercy Health Blvd Cincinnati Ohio 45211 —
Oncology Hematology Care - Malsbary Rd Cincinnati Ohio 45242 —
Oncology Hematology Care - Ivy Gateway Cincinnati Ohio 45245 —
Oncology Hematology Care - Fairfield Fairfield Ohio 45014 —
Northwest Cancer Specialists - NE Hoyt St Portland Oregon 97213-2982 —
Northwest Cancer Specialists - N. Broadway Portland Oregon 97227 —
Northwest Cancer Specialists Tigard Oregon 97223 —
Consultants in Medical Oncology and Hematology Broomall Pennsylvania 19008 —
Consultants in Medical Oncology and Hematology Horsham Pennsylvania 19044 —
Consultants in Medical Oncology and Hematology Wynnewood Pennsylvania 19096 —
Texas Oncology - West Texas Amarillo Amarillo Texas 79106 —
Texas Oncology - Beaumont Beaumont Texas 77701 —
Texas Oncology - Beaumont Mamie McFaddin Ward Cancer Center Beaumont Texas 77702-1449 —
Texas Oncology - Carrollton Carrollton Texas 75010 —
Texas Oncology - Denton Denton Texas 76201 —
Texas Oncology - Flower Mound Flower Mound Texas 75028 —
Texas Oncology Cancer Care and Research Harlingen Texas 78550 —
Texas Oncology - Longview Cancer Center Longview Texas 75601 —
Texas Oncology - McAllen McAllen Texas 78503 —
Texas Oncology - West Texas Midland Midland Texas 79701 —
Texas Oncology - West Texas Odessa Odessa Texas 79761 —
Texas Oncology - Sherman Sherman Texas 75090 —
Texas Oncology - Tyler Tyler Texas 75702 —
Texas Oncology - Weslaco Weslaco Texas 78596 —
Texas Oncology - West Texas Wichita Falls Wichita Falls Texas 76310 —
Virginia Oncology Associaties Chesapeake Virginia 23320 —
Virginia Oncology Associates Hampton Virginia 23666 —
Virginia Oncology Associates Newport News Virginia 23606 —
Virginia Cancer Specialists Norfolk Virginia 23502 —
Virginia Oncology Associates Virginia Beach Virginia 23456 —
Northwest Cancer Specialists Vancouver Washington 98684 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04698681, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 13, 2023 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04698681 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →